Sinopharm Group Co.-Unsp ADRSHTDY
13F holders, Q1 2025 (March 31)3holders
0new positions
0sold out
$11.56avg. 13F price*
At the end of Q1 2025, 3 institutions reported holding Sinopharm Group Co.-Unsp ADR (SHTDY) in their 13F filings, unchanged from Q4 2024. 0 opened new positions and 0 sold out. The largest holders were Rhumbline Advisers ($13K), GAMMA Investing LLC ($2K) and PNC Financial Services Group, Inc. ($1K).
- Company
- Sinopharm Group Co.-Unsp ADR
- CUSIP
- 82937K101
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q4 2024 → Q1 2025: 133 shares sold, net −133 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| Rhumbline Advisers | 0.00% | No change | 1,101 | $13K |
| GAMMA Investing LLC | 0.00% | No change | 205 | $2K |
| PNC Financial Services Group, Inc. | 0.00% | Reduce -52.0% | 123 | $1K |
"% of holder's portfolio" is SHTDY's weight in each manager's 13F, not the share of Sinopharm Group Co.-Unsp ADR the manager owns.